HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer In Children

Cancer in children is a devastating and challenging reality that impacts the lives of young individuals and their families. Unlike cancer in adults, pediatric cancers are relatively rare, but they present unique and complex challenges. Children can develop various types of cancer, including leukemia, brain tumors, and neuroblastoma, among others. The causes of childhood cancer are not always clear, and it often occurs sporadically without identifiable risk factors. Genetic factors, exposure to certain substances, and compromised immune function are some potential contributors. One of the distinct features of pediatric cancer is its rapid and aggressive nature. Children's bodies may respond differently to treatment compared to adults, and the impact of cancer and its treatments on their developing organs can be significant. The emotional toll on families is immense, as parents grapple with the shock of a cancer diagnosis and the uncertainties that lie ahead. Treatment modalities for childhood cancer typically include a combination of surgery, chemotherapy, and radiation therapy. Advances in medical research have led to improved survival rates in recent years, offering hope to affected families. However, the long-term effects of treatment, including potential impacts on growth and development, remain concerns. Supportive care plays a crucial role in helping children and their families navigate the challenges of cancer treatment. Pediatric oncology teams often collaborate with psychologists, social workers, and other specialists to address not only the physical aspects of the disease but also the emotional and psychosocial well-being of the child and their family.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp